K B Institute of Pharmaceutical Education and Research | India
Author Profile
Scopus
EARLY ACADEMIC PURSUITS
Bijina Balakrishnan embarked on her academic journey in the field of biotechnology with a Bachelor of Science degree in Biology & Chemistry from the University of Calicut, Kerala, India, in 1999. She continued her pursuit of knowledge with a Master of Science in Biotechnology from Cochin University of Science and Technology, Kerala, India, in 2002. This was followed by a significant milestone in her academic career, as she obtained her Doctor of Philosophy (PhD) in Biotechnology from Cochin University of Science and Technology, Kerala, India, in 2008.
PROFESSIONAL ENDEAVORS
Balakrishnan's professional journey has been characterized by a commitment to advancing scientific knowledge and addressing critical medical challenges. From her early research experiences in India to her post-doctoral positions in Singapore and the United States, she has consistently contributed to various facets of biotechnological research.
Throughout her career, Balakrishnan has made significant contributions to the fields of biotechnology and biomedical research. Her research efforts have encompassed a diverse range of topics, including enzymology, protein biochemistry, gene therapy, and rare metabolic disorders. Notably, she has focused on elucidating the molecular mechanisms underlying diseases such as Classic Galactosemia and dilated cardiomyopathy, with the aim of developing innovative therapeutic strategies Pharmaceutical Analytical Chemistry Award.
IMPACT AND INFLUENCE
Balakrishnan's work has had a profound impact on both scientific understanding and clinical practice. By conducting translational research and collaborating with industry partners, she has advanced our knowledge of disease pathophysiology and facilitated the development of novel treatments. Her contributions have the potential to improve the lives of individuals affected by rare genetic disorders and cardiovascular diseases.
ACADEMIC CITATIONS
Balakrishnan's research findings have been disseminated widely through academic publications and presentations at international conferences. Her work has been cited by fellow researchers, contributing to the advancement of scientific knowledge in her areas of expertise.
LEGACY AND FUTURE CONTRIBUTIONS
As she continues her academic and professional journey, Balakrishnan's legacy is defined by her dedication to scientific inquiry and her commitment to improving human health. Her future contributions are poised to further expand our understanding of disease mechanisms and pave the way for the development of innovative therapies.
NOTABLE PUBLICATIONS
Development and validation of stability indicating RP-HPLC method for simultaneous estimation of silodosin and mirabegron in synthetic mixture 2024(2)
Isolation, identification and structural characterization of forced degradation products of mobocertinib using LC-MS/MS and NMR 2024
LC-MS/MS and NMR Studies for Identification and Characterization of Forced Degradation Products of Acalabrutinib 2023(1)